schedule13_d.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
(Rule 13d-101)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a)
Under the Securities Exchange Act of 1934
(Amendment No. 4)*
Supertex, Inc.
(Name of Issuer)
Common Stock, no par value
(Title of Class of Securities)
868532102
(CUSIP Number)
J. Eric Bjornholt
Vice President and Chief Financial Officer
Microchip Technology Incorporated
2355 West Chandler Boulevard
Chandler, Arizona 85224-6199
(480) 792-7200
With a Copy to:
J. Robert Suffoletta
Wilson Sonsini Goodrich & Rosati
650 Page Mill Rd.
Palo Alto, CA 94304
(650) 493-9300
(Name, Address and Telephone Number of Person Authorized to
Receive Notices and Communications)
August 28, 2009
(Date of Event Which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. o
Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent.
* The remainder of this cover page shall be filled out for a Reporting Person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
CUSIP No: 868532102 |
Schedule 13D |
Page 2 of 6 Pages |
1. |
NAMES OF REPORTING PERSONS
Microchip Technology Incorporated
|
2. |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(See Instructions) |
(a)o
(b)o
|
3. |
SEC USE ONLY
|
4. |
SOURCE OF FUNDS (See Instructions)
Not applicable.
|
5. |
CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(D) OR 2(E)
|
o |
6. |
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH |
|
7. |
SOLE VOTING POWER
689,499
|
8. |
SHARED VOTING POWER
0
|
9. |
SOLE DISPOSITIVE POWER
689,499
|
10. |
SHARED DISPOSITIVE POWER
0
|
11. |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
689,499
|
12. |
CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES (See Instructions)
|
o |
13. |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
5.3%
|
14. |
TYPE OF REPORTING PERSON (See Instructions)
CO
|
CUSIP No: 868532102 |
Schedule 13D |
Page 3 of 6 Pages |
Item 1. |
Security and Issuer |
This Amendment No. 4 to Statement on Schedule 13D (this “Schedule 13D”) amends and restates Amendment No. 3 to the Statement on Schedule 13D filed on August 21, 2009 and reports the sale of an aggregate of 263,950 shares
of the common stock, no par value (the “Common Stock”), of Supertex, Inc., a California corporation (the “Issuer”), having its principal executive offices at 1235 Bordeaux Drive, Sunnyvale, California 94086.
Item 2. |
Identity and Background |
This Amendment No. 4 to Schedule 13D is being filed by Microchip Technology Incorporated, a Delaware corporation (“Microchip” or the “Reporting Person”). The address of the principal
business office of Microchip is 2355 West Chandler Boulevard, Chandler, Arizona 85224-6199.
The principal business of Microchip is the development and manufacturing of specialized semiconductor products used by its customers for a wide variety of embedded control applications.
The name, present principal occupation or employment, present business address and country of citizenship of each director and executive officer of Microchip is set forth on Schedule I attached hereto.
During the past five years, neither Microchip nor, to the best of Microchip’s knowledge, any director or executive officer of Microchip, has been (i) convicted of a criminal proceeding (excluding traffic violations or similar misdemeanors) or (ii) a party to a civil proceeding of a judicial or administrative body of competent jurisdiction
and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.
Item 3. |
Source and Amount of Funds or Other Consideration |
Not applicable.
Item 4. |
Purpose of Transaction |
This Amendment No. 4 is being filed in connection with the sale of an aggregate of 263,950 shares of Common Stock as described in Item 5. Microchip acquired certain of the shares reported in this Schedule 13D as being beneficially owned by
Microchip in open market transactions prior to May 13, 2008. Microchip acquired certain other shares reported in this Schedule 13D as being beneficially owned by Microchip in accordance with certain put option transactions Microchip had previously entered into. Microchip has no current intention to acquire or sell additional shares of the Issuer's common stock except as described herein, although Microchip may do so depending on market conditions and other factors that it deems appropriate
in its sole discretion. Microchip may also acquire or sell additional shares of the Issuer's common stock as it deems appropriate, whether in open market purchases, privately negotiated transactions or otherwise. Microchip and/or its advisors may enter into or engage in discussions with the Issuer concerning an event referred to in paragraphs (a) through (j), inclusive, of Item 4 of Schedule 13D. Microchip and/or its advisors may also engage in discussions with other market participants
and/or other stockholders of the Issuer concerning the issuer, as Microchip deems advisable or appropriate. Microchip also reserves the right to dispose of some or all of the shares of Common Stock at any time in the open market, in privately negotiated transactions to third parties or otherwise as it deems appropriate in its sole discretion. Any of the foregoing actions could lead to one or more of the events referred to in paragraphs (a) through (j), inclusive, of Item 4 of Schedule 13D, including,
potentially, one or more mergers, consolidations, sales or acquisitions of assets, change in control, issuances, purchases, dispositions or pledges of securities or other changes in capitalization.
Item 5. |
Interest in Securities of the Issuer |
(a), (b) According to the Issuer’s Quarterly Report on Form 10-Q for the Quarter Ended June 27, 2009, filed with the Securities and Exchange Commission on August 6, 2009, there were 12,897,899 shares of Common Stock issued and outstanding as of August 3, 2009. Based on such information and including the transactions
described in Item 5(c) below, Microchip reports beneficial ownership of 689,499 shares of Common Stock, which represents 5.3% of the total number of issued and outstanding shares of Common Stock. Voting and dispositive power with respect to such shares of Common Stock is held solely by Microchip.
CUSIP No: 868532102 |
Schedule 13D |
Page 4 of 6 Pages |
(c) Since August 21, 2009, the date Microchip filed Amendment No. 3 to the Statement on Schedule 13D, Microchip did not purchase any shares of Common Stock. Since August 21, 2009, Microchip sold the following shares of Common Stock in the open market:
Trade Date |
|
Shares |
|
|
Price / Share |
|
August 24, 2009 |
|
|
27,320 |
|
|
$ |
26.0552 |
|
August 25, 2009 |
|
|
34,500 |
|
|
$ |
26.0066 |
|
August 26, 2009 |
|
|
25,805 |
|
|
$ |
26.0626 |
|
August 27, 2009 |
|
|
30,800 |
|
|
$ |
25.7319 |
|
August 28, 2009 |
|
|
50,100 |
|
|
$ |
26.1966 |
|
August 31, 2009 |
|
|
89,525 |
|
|
$ |
25.8022 |
|
September 1, 2009 |
|
|
5,900 |
|
|
$ |
25.8440 |
|
Other than the transactions disclosed above, neither Microchip nor, to the best of Microchip’s knowledge, any director or executive officer of Microchip, has engaged in any transactions in shares of Common Stock since August 21, 2009.
(d), (e) Not applicable.
Item 6. |
Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer |
There are currently no contracts, arrangements, understandings or relationships (legal or otherwise) between Microchip or, to the best of Microchip’s knowledge, any director or executive officer of Microchip, and any person with respect to any securities of the Issuer, including but not limited to, transfer or voting of any of the securities
of the Issuer, finder’s fees, joint ventures, loan or option arrangements, puts or calls, guarantees of profits, division of profits or loss, or the giving or withholding of proxies.
Item 7. |
Material to Be Filed as Exhibits |
None.
CUSIP No: 868532102 |
Schedule 13D |
Page 5 of 6 Pages |
Signature
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Dated: September 1, 2009 |
MICROCHIP TECHNOLOGY INCORPORATED |
|
|
|
By: /s/ J. Eric Bjornholt |
|
J. Eric Bjornholt
Vice President, Chief Financial Officer
(Principal Accounting and Financial Officer) |
CUSIP No: 868532102 |
Schedule 13D |
Page 6 of 6 Pages |
SCHEDULE I
MICROCHIP TECHNOLOGY INCORPORATED
DIRECTORS AND EXECUTIVE OFFICERS
Name |
|
Present
Principal Occupation |
|
Present
Business Address |
|
Country of Citizenship |
Steve Sanghi |
|
President, Chief Executive Officer and Chairman of the Board of Microchip Technology Incorporated |
|
Microchip Technology Incorporated
2355 West Chandler Boulevard
Chandler, Arizona 85224-6199 |
|
United States |
|
|
|
|
|
|
|
Ganesh Moorthy |
|
Executive Vice President and Chief Operating Officers of Microchip Technology Incorporated |
|
Microchip Technology Incorporated
2355 West Chandler Boulevard
Chandler, Arizona 85224-6199 |
|
United States |
|
|
|
|
|
|
|
Matthew W. Chapman |
|
Director of Microchip Technology Incorporated
President and Chief Executive Officer of Northwest Evaluation Association |
|
Northwest Evaluation Association
5885 S.W. Meadow Rd, #200
Lake Oswego, OR 97035 |
|
United States |
|
|
|
|
|
|
|
L.B. Day |
|
Director of Microchip Technology Incorporated
President of L.B. Day & Company, Inc. |
|
L.B. Day & Co.
806 S.W. Broadway, 11th Flr.
Portland, OR 97205-3313 |
|
United States |
|
|
|
|
|
|
|
Albert J. Hugo-Martinez |
|
Director of Microchip Technology Incorporated
Chief Executive Officer of Hugo-Martinez Associates |
|
Hugo-Martinez and Associates
1366 Via Alta
Del Mar, CA 92014 |
|
United States |
|
|
|
|
|
|
|
Wade F. Meyercord |
|
Director of Microchip Technology Incorporated
President of Meyercord & Associates, Inc. |
|
Meyercord & Associates, Inc.
16187 Greenwood Lane
Los Gatos, CA 95030 |
|
United States |
|
|
|
|
|
|
|
J. Eric Bjornholt |
|
Vice President, Chief Financial Officer of Microchip Technology Incorporated |
|
Microchip Technology Incorporated
2355 West Chandler Boulevard
Chandler, Arizona 85224-6199 |
|
United States |
|
|
|
|
|
|
|
Stephen V. Drehobl |
|
Vice President, Security, Microcontroller and Technology Division of Microchip Technology Incorporated |
|
Microchip Technology Incorporated
2355 West Chandler Boulevard
Chandler, Arizona 85224-6199 |
|
United States |
|
|
|
|
|
|
|
David S. Lambert |
|
Vice President, Fab Operations of Microchip Technology Incorporated |
|
Microchip Technology Incorporated
2355 West Chandler Boulevard
Chandler, Arizona 85224-6199 |
|
United States |
|
|
|
|
|
|
|
Mitchell R. Little |
|
Vice President, Worldwide Sales and Applications of Microchip Technology Incorporated |
|
Microchip Technology Incorporated
2355 West Chandler Boulevard
Chandler, Arizona 85224-6199 |
|
United States |
|
|
|
|
|
|
|
Richard J. Simoncic |
|
Vice President, Analog and Interface Products Division of Microchip Technology Incorporated |
|
Microchip Technology Incorporated
2355 West Chandler Boulevard
Chandler, Arizona 85224-6199 |
|
United States |